NASDAQ:CLXT - Calyxt Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $17.41 -0.30 (-1.69 %) (As of 07/17/2018 01:34 AM ET)Previous Close$17.71Today's Range$17.01 - $17.7252-Week Range$9.26 - $31.89Volume59,100 shsAverage Volume90,234 shsMarket Capitalization$496.25 millionP/E Ratio-15.54Dividend YieldN/ABetaN/A Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in New Brighton, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A. Receive CLXT News and Ratings via Email Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorConsumer Staples SymbolNASDAQ:CLXT CUSIPN/A Webwww.calyxt.com Phone651-683-2807 Debt Debt-to-Equity Ratio0.27 Current Ratio17.79 Quick Ratio17.79 Price-To-Earnings Trailing P/E Ratio-15.54 Forward P/E Ratio-16.42 P/E GrowthN/A Sales & Book Value Annual Sales$510,000.00 Price / Sales956.53 Cash FlowN/A Price / CashN/A Book Value$2.08 per share Price / Book8.37 Profitability EPS (Most Recent Fiscal Year)($1.12) Net Income$-25,980,000.00 Net Margins-5,930.60% Return on Equity-60.81% Return on Assets-46.54% Miscellaneous Employees35 Outstanding Shares28,020,000Market Cap$496.25 Calyxt (NASDAQ:CLXT) Frequently Asked Questions What is Calyxt's stock symbol? Calyxt trades on the NASDAQ under the ticker symbol "CLXT." How were Calyxt's earnings last quarter? Calyxt Inc (NASDAQ:CLXT) issued its earnings results on Monday, May, 7th. The company reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.13. The company earned $0.01 million during the quarter, compared to analysts' expectations of $0.20 million. Calyxt had a negative return on equity of 60.81% and a negative net margin of 5,930.60%. View Calyxt's Earnings History. What price target have analysts set for CLXT? 5 brokerages have issued 12-month target prices for Calyxt's stock. Their predictions range from $22.00 to $34.25. On average, they anticipate Calyxt's share price to reach $29.05 in the next year. This suggests a possible upside of 66.9% from the stock's current price. View Analyst Ratings for Calyxt. What is the consensus analysts' recommendation for Calyxt? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." What are Wall Street analysts saying about Calyxt stock? Here are some recent quotes from research analysts about Calyxt stock: 1. Jefferies Financial Group Inc analysts commented, "CLXT announced in an 8-K filing that CFO Bryan Corkal has resigned from the company effective immediately. While the announcement was unexpected, we believe it was a personal decision & not the result of any disagreement with the company or a sign of any operational / financial issues. In fact, we are incrementally positive on near term fundamentals following meetings with mgmt earlier this week." (6/22/2018) 2. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (5/28/2018) Are investors shorting Calyxt? Calyxt saw a drop in short interest in the month of May. As of May 31st, there was short interest totalling 979,568 shares, a drop of 27.4% from the May 15th total of 1,348,920 shares. Based on an average trading volume of 260,070 shares, the days-to-cover ratio is currently 3.8 days. Approximately 10.6% of the shares of the company are short sold. View Calyxt's Current Options Chain. Who are some of Calyxt's key competitors? Some companies that are related to Calyxt include Terra Nitrogen (TNH), American Vanguard (AVD), CVR Partners (UAN), Marrone Bio Innovations (MBII), Wynnstay Group (WYN), Evogene (EVGN), China Green Agriculture (CGA), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT), Eden Research (EDEN), Arcadia Biosciences (RKDA), Bion Environmental Technologies (BNET), Cavitation Technologies (CVAT) and Syngenta (SYT). Who are Calyxt's key executives? Calyxt's management team includes the folowing people: Mr. Federico A. Tripodi, Chief Exec. Officer (Age 41)Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 55)Mr. Eric Dutang, Interim CFO & Principal Accounting Officer (Age 44)Simon Harnest, VP of Fin. & Investor RelationsMs. Jennifer Moore, VP of Communications When did Calyxt IPO? (CLXT) raised $101 million in an initial public offering (IPO) on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers. Has Calyxt been receiving favorable news coverage? Media coverage about CLXT stock has trended somewhat positive recently, Accern reports. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Calyxt earned a media sentiment score of 0.07 on Accern's scale. They also gave press coverage about the company an impact score of 44.78 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days. How do I buy shares of Calyxt? Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Calyxt's stock price today? One share of CLXT stock can currently be purchased for approximately $17.41. How big of a company is Calyxt? Calyxt has a market capitalization of $496.25 million and generates $510,000.00 in revenue each year. The company earns $-25,980,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Calyxt employs 35 workers across the globe. How can I contact Calyxt? Calyxt's mailing address is 600 COUNTY ROAD D WEST SUITE 8, NEW BRIGHTON MN, 55112. The company can be reached via phone at 651-683-2807 or via email at [email protected] MarketBeat Community Rating for Calyxt (NASDAQ CLXT)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 113 (Vote Outperform)Underperform Votes: 109 (Vote Underperform)Total Votes: 222MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: How do investors use RSI to grade stocks?